Creating an effective bioaugmentation product (bugs) for use in wastewater systems in a multiple step process that involves screening multiple candidates and creating a decision matrix before selecting the ideal candidate for inclusion into a formulation. We spend significant amounts of time characterizing strains for environmental growth conditions and degradation capabilities. Additionally, complexities arise when you make a product with both spore forming and vegetative strains. In fact, many companies limit their product to spore forming microbes even if that means losing an large amount of metabolic diversity. Below, I have outlined the R&D process we use at Aster Bio (www.asterbio.com).
Erik Rumbaugh has been involved in biological waste treatment for over 20 years. He has worked with industrial and municipal wastewater facilities to ensure optimal performance of their treatment systems. He is a founder of Aster Bio (www.asterbio.com) specializing in biological waste treatment.
Click to set custom HTML